Lars Wallentin

Part of EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, p. 427-436, 2009

The SCAAR-scare in perspective

James, Stefan K.; Wallentin, Lars; Lagerqvist, Bo

Part of EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, p. 501-504, 2009

Raised Interleukin-10 is an Indicator of Poor Outcome and Enhanced Systemic Inflammation in Patients with Acute Coronary Syndrome

Mälarstig, Anders; Eriksson, Per; Hamsten, Anders; Lindahl, Bertil et al.

Part of Heart, p. 724-9, 2008

DOI for Raised Interleukin-10 is an Indicator of Poor Outcome and Enhanced Systemic Inflammation in Patients with Acute Coronary Syndrome

Pathophysiologic mechanisms and prognostic value of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.

Eggers, Kai; Lagerqvist, Bo; Venge, Per; Wallentin, Lars et al.

Part of American Heart Journal, p. 588-94, 2008

DOI for Pathophysiologic mechanisms and prognostic value of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.

Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease

Braun, Oscar O.; Johnell, Matilda; Varenhorst, Christoph; James, Stefan et al.

Part of Thrombosis and Haemostasis, p. 626-633, 2008

DOI for Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease

New frontiers in the management of arterial thrombosis with oral anticoagulants

Wallentin, Lars C.

Part of Thrombosis and Haemostasis, 2008

Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA)

Norhammar, Anna; Stenestrand, U.; Lindbäck, J.; Wallentin, Lars

Part of Heart, p. 1565-70, 2008

DOI for Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA)

Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome

Eggers, Kai M.; Lagerqvist, Bo; Oldgren, Jonas; Venge, Per et al.

Part of American Heart Journal, p. 588-594, 2008

DOI for Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

Wallentin, Lars; Varenhorst, Christoph; James, Stefan; Erlinge, David et al.

Part of European Heart Journal, p. 21-30, 2008

DOI for Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

Erlinge, David; Varenhorst, Christoph; Braun, Oscar O; James, Stefan et al.

Part of Journal of the American College of Cardiology, p. 1968-77, 2008

DOI for Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

Population pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in aspirin-treated patients with stable coronary artery disease

Ernest, C. Steven; Small, David S.; Rohatagi, Shashank; Salazar, Daniel E. et al.

Part of Journal of Pharmacokinetics and Pharmacodynamics, p. 593-618, 2008

DOI for Population pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in aspirin-treated patients with stable coronary artery disease

Nationella riktlinjer för hjärtsjukvård 2008: Prioriteringar kräver hänsyn till flera faktorer än vetenskapliga studier!

Eklund, Kristina; Grip, Lars; Israelsson, Bo; Levin, Lars-Åke et al.

Part of Läkartidningen, p. 1408-9; discussion 1409, 2008

Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005

Jackson, Kevin; Gersh, Bernard J.; Stockbridge, Norman; Fleming, Thomas R. et al.

Part of American Heart Journal, p. 829-40, 2008

DOI for Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005

Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain

Eggers, Kai M.; Kempf, Tibor; Allhoff, Tim; Lindahl, Bertil et al.

Part of European Heart Journal, p. 2327-2335, 2008

DOI for Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain

The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial

Peters, Ron J. G.; Joyner, Campbell; Bassand, Jean-Pierre; Afzal, Rizwan et al.

Part of European Heart Journal, p. 324-331, 2008

DOI for The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial

Blodproppshämmande behandling vid förmaksflimmer: Bakgrund till nya rekommendationer och behandlingsalternativ

Själander, Anders; Wallentin, Lars; Rosenqvist, Mårten; Svensson, Peter J.

Part of Läkartidningen, p. 2478-80, 2008

Svenskt arbete med nationella riktlinjer kan bli internationellt föredöme: Med perspektiv från riktlinjerna vid hjärtsjukdom

Wallentin, Lars; Lindahl, Bertil; Kärvinge, Christina; Eklund, Kristina et al.

Part of Läkartidningen, p. 1194-7, 2008

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation

Lopes, R. D.; Pieper, K. S.; Horton, J. R.; Al-Khatib, S. M. et al.

Part of Heart, p. 867-73, 2008

DOI for Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation

Risk stratification in ST elevation myocardial infarction is enhanced by combining baseline ST deviation and subsequent ST segment resolution

Toma, Mustafa; Fu, Yuling; Wagner, Galen S.; Goodman, Shaun et al.

Part of Heart, 2008

DOI for Risk stratification in ST elevation myocardial infarction is enhanced by combining baseline ST deviation and subsequent ST segment resolution

Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment

Oldgren, Jonas; Wallentin, Lars; Afzal, Rizwan; Bassand, Jean-Pierre et al.

Part of European Heart Journal, p. 315-23, 2008

DOI for Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment

Dual antiplatelet therapy in the drug-eluting stent era

Wallentin, Lars

Part of European Heart Journal, Supplement, 2008

DOI for Dual antiplatelet therapy in the drug-eluting stent era

Growth-differentiation factor-15 for risk stratification in patients with acute chest pain: reply

Eggers, Kai M.; Wallentin, Lars; Wollert, Kai C.

Part of European Heart Journal, p. 2947-2948, 2008

DOI for Growth-differentiation factor-15 for risk stratification in patients with acute chest pain: reply

Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction

Mälarstig, Anders; Sigurdsson, Snaevar; Eriksson, Per; Paulsson-Berne, Gabrielle et al.

Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 975-982, 2008

DOI for Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction

Why don't we return to bare metal stents?

Hess, Otto M.; Karjalainen, Pasi; James, Stefan; Wallentin, Lars et al.

Part of EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, p. 36-41, 2008

Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality

Eggers, Kai; Lagerqvist, Bo; Venge, Per; Wallentin, Lars et al.

Part of Circulation, p. 1907-1914, 2007

DOI for Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality

Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: A time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission

Norhammar, Anna; Lindbäck, Johan; Rydén, Lars; Wallentin, Lars et al.

Part of Heart, p. 1577-1583, 2007

DOI for Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: A time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission

Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction - Reply

Stenestrand, Ulf; Lindbäck, Johan; Wallentin, Lars

Part of Journal of the American Medical Association (JAMA), p. 1314-1315, 2007

DOI for Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction - Reply

Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischemic events: Observations from the ESTEEM trial

Christersson, Christina; Oldgren, Jonas; Bylock, Anders; Siegbahn, Agneta et al.

Part of European Heart Journal, p. 692-698, 2007

DOI for Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischemic events: Observations from the ESTEEM trial

Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay

Kempf, Tibor; Horn-Wichmann, Rüdiger; Brabant, Georg; Peter, Timo et al.

Part of Clinical Chemistry, p. 284-291, 2007

DOI for Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay

Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

Hernández, Adrián V.; Westerhout, Cynthia M.; Steyerberg, Ewout W.; Ioannidis, John P. A. et al.

Part of Heart, p. 450-455, 2007

DOI for Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM: Reply

Christersson, Christina; Oldgren, Jonas; Bylock, Anders; Siegbahn, Agneta et al.

Part of European Heart Journal, p. 1783-1783, 2007

DOI for Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM: Reply

Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients

Oldgren, Jonas; James, Stefan; Siegbahn, Agneta; Wallentin, Lars

Part of European Heart Journal, p. 699-704, 2007

DOI for Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients

Management of pregnant women with artificial heart valves: inconsistency in ESC publications: reply

Husted, Steen; Wallentin, Lars; De Caterina, Raffaele

Part of European Heart Journal, p. 2419-2420, 2007

DOI for Management of pregnant women with artificial heart valves: inconsistency in ESC publications: reply

Hjärtinfarktvården kraftigt förbättrad 1995-2005: Kvalitetsregister, öppna redovisningar och tydliga terapimål har gett resultat

Stenestrand, Ulf; Lindahl, Bertil; Wallentin, Lars

Part of Läkartidningen, p. 1580-1583, 2007

Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women

Westerhout, Cynthia M.; Lauer, Michael S.; James, Stefan; Fu, Yuling et al.

Part of European Heart Journal, p. 2064-2069, 2007

DOI for Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women

No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial

Westerhout, Cynthia M.; Gnarpe, Judy; Chang, Wei-Ching; FitzPatrick, Susan et al.

Part of American Heart Journal, p. 306-312, 2007

DOI for No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial

Influence of left bundle branch block on long-term mortality in a population with heart failure

Tabrizi, Fariborz; Englund, Anders; Rosenqvist, Mårten; Wallentin, Lars et al.

Part of European Heart Journal, p. 2449-2455, 2007

DOI for Influence of left bundle branch block on long-term mortality in a population with heart failure

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden

Lagerqvist, Bo; James, Stefan; Stenestrand, Ulf; Lindbäck, Johan et al.

Part of New England Journal of Medicine, p. 1009-1019, 2007

DOI for Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden

Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study)

Ezekowitz, Michael D.; Reilly, Paul A.; Nehmiz, Gerhard; Simmers, Timothy A. et al.

Part of American Journal of Cardiology, p. 1419-1426, 2007

DOI for Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study)

Cardiovascular disease on a global scale: defining the path forward for research and practice

Mark, Daniel B.; Van de Werf, Frans J.; Simes, R. John; White, Harvey D. et al.

Part of European Heart Journal, p. 2678-2684, 2007

DOI for Cardiovascular disease on a global scale: defining the path forward for research and practice

Universal definition of myocardial infarction

Thygesen, Kristian; Alpert, Joseph S.; White, Harvey D.; Jaffe, Allan S. et al.

Part of Circulation, p. 2634-53, 2007

DOI for Universal definition of myocardial infarction

Guía de Práctica Clínica para el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST

Bassand, Jean-Pierre; Hamm, Christian W; Ardissino, Diego; Boersma, Eric et al.

Part of Revista Española de Cardiología, p. 1070-1080, 2007

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial

Mehta, Shamir R.; Granger, Christopher B.; Eikelboom, John W.; Bassand, Jean-Pierre et al.

Part of Journal of the American College of Cardiology, p. 1742-1751, 2007

DOI for Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial

Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction

Kempf, Tibor; Björklund, Erik; Olofsson, Sylvia; Lindahl, Bertil et al.

Part of European Heart Journal, p. 2858-2865, 2007

DOI for Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction

Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non-ST-Elevation Acute Coronary Syndrome

Wollert, Kai C; Kempf, Tibor; Lagerqvist, Bo; Lindahl, Bertil et al.

Part of Circulation, p. 1540-1548, 2007

DOI for Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non-ST-Elevation Acute Coronary Syndrome

Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non-ST-segment elevation acute coronary syndromes

Fox, Keith A.; Bassand, Jean-Pierre; Mehta, Shamir R.; Wallentin, Lars et al.

Part of Annals of Internal Medicine, p. 304-310, 2007

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

Bassand, Jean-Pierre; Hamm, Christian W; Ardissino, Diego; Boersma, Eric et al.

Part of European Heart Journal, p. 1598-1660, 2007

DOI for Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies

Bugiardini, Raffaele; Badimon, Lina; Collins, Peter; Erbel, Raimund et al.

Part of PLoS Medicine, 2007

DOI for Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome

Wollert, Kai C.; Kempf, Tibor; Peter, Timo; Olofsson, Sylvia et al.

Part of Circulation, p. 962-971, 2007

DOI for Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome

Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome

Mälarstig, Anders; Wallentin, Lars; Siegbahn, Agneta

Part of Thrombosis Research, p. 467-473, 2007

DOI for Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome

Gender differences in management and outcome in Non-ST-Elevation Acute Coronary Syndrome

Alfredsson, Joakim; Stenestrand, Ulf; Wallentin, Lars; Swahn, Ewa

Part of Heart, p. 1357-1362, 2007

DOI for Gender differences in management and outcome in Non-ST-Elevation Acute Coronary Syndrome

Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease

Johnston, Nina; Jernberg, Tomas; Lagerqvist, Bo; Wallentin, Lars

Part of American Heart Journal, p. 1052-1058, 2006

DOI for Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease

Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers

Johnston, Nina; Jernberg, Tomas; Lagerqvist, Bo; Siegbahn, Agneta et al.

Part of American Journal of Cardiology, p. 640-5, 2006

DOI for Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers

Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease

Johnston, Nina; Jernberg, Tomas; Lagerqvist, Bo; Siegbahn, Agneta et al.

Part of International Journal of Cardiology, p. 167-173, 2006

DOI for Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease

Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome

Mälarstig, Anders; Lindahl, Bertil; Wallentin, Lars; Siegbahn, Agneta

Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 1667-1673, 2006

DOI for Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Jernberg, Tomas; Payne, Christopher D.; Winters, Kenneth J.; Darstein, Christelle et al.

Part of European Heart Journal, p. 1166-1173, 2006

DOI for Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy

James, Stefan K.; Lindbäck, Johan; Tilly, Johanna; Siegbahn, Agneta et al.

Part of Journal of the American College of Cardiology, p. 1146-1154, 2006

DOI for Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy

Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials

Al-Faleh, Hussam; Fu, Yuling; Wagner, Galen; Goodman, Shaun et al.

Part of American Heart Journal, p. 10-5, 2006

DOI for Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials

Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (A GUSTO IV substudy)

James, Stefan K.; Lindahl, Bertil; Timmer, Jorik R.; Ottervanger, Jan Paul et al.

Part of American Journal of Cardiology, p. 167-172, 2006

DOI for Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (A GUSTO IV substudy)

The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004

Mandelzweig, Lori; Battler, Alex; Boyko, Valentina; Bueno, Hector et al.

Part of European Heart Journal, p. 2285-2293, 2006

DOI for The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004

Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction

Chang, Wei-Ching; Kaul, Padma; Fu, Yuling; Westerhout, Cynthia M. et al.

Part of European Heart Journal, p. 419-426, 2006

DOI for Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction

Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study

Carlhed, Rickard; Bojestig, Mats; Wallentin, Lars; Lindström, Gunilla et al.

Part of American Heart Journal, p. 1175-1181, 2006

DOI for Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study

Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes

Westerhout, Cynthia M.; Hernández, Adrián V.; Steyerberg, Ewout W.; Bueno, Héctor et al.

Part of European Heart Journal, p. 2956-2961, 2006

DOI for Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

Yusuf, Salim; Mehta, Shamir R.; Chrolavicius, Susan; Afzal, Rizwan et al.

Part of New England Journal of Medicine, p. 1464-1476, 2006

Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers

Westerhout, Cynthia M.; Fu, Yuling; Lauer, Michael S.; James, Stefan et al.

Part of Journal of the American College of Cardiology, p. 939-947, 2006

DOI for Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers

Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction

Björklund, Erik; Stenestrand, Ulf; Lindbäck, Johan; Svensson, Leif et al.

Part of European Heart Journal, p. 1146-1152, 2006

DOI for Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction

5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study

Lagerqvist, Bo; Husted, Steen; Kontny, Fredrik; Ståhle, Elisabeth et al.

Part of The Lancet, p. 998-1004, 2006

DOI for 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study

Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction

Björklund, Erik; Jernberg, T.; Johanson, P.; Venge, Per et al.

Part of Heart, p. 735-740, 2006

DOI for Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction

Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes

Lenderink, Timo; Boersma, Eric; Gitt, Anselm K.; Zeymer, Uwe et al.

Part of European Heart Journal, p. 1799-1804, 2006

DOI for Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

Rosengren, Annika; Wallentin, Lars; Simoons, Maarten; Gitt, Anselm K. et al.

Part of European Heart Journal, p. 789-795, 2006

DOI for Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

Yusuf, Salim; Mehta, Shamir R.; Chrolavicius, Susan; Afzal, Rizwan et al.

Part of Journal of the American Medical Association (JAMA), p. 1519-1930, 2006

Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data

Armstrong, Paul W.; Chang, Wei-Ching; Wallentin, Lars; Goldstein, Patrick et al.

Part of CMJA. Canadian Medical Association Journal. Onlineutg. Med tittel, p. 1421-1426, 2006

DOI for Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data

Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS

Sinnaeve, Peter R.; Huang, Yao; Bogaerts, Kris; Vahanian, Alec et al.

Part of American Heart Journal, p. 6840, 2006

DOI for Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS

Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction

Stenestrand, Ulf; Lindbäck, Johan; Wallentin, Lars

Part of Journal of the American Medical Association (JAMA), p. 1749-1756, 2006

DOI for Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction

Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers

Johnston, Nina; Jernberg, Tomas; Lagerqvist, Bo; Siegbahn, Agneta et al.

Part of American Journal of Cardiology, p. 640-5, 2006

Cardiovascular risk factors and clinical presentation in acute coronary syndromes

Rosengren, A; Wallentin, Lars; Simoons, M; Gitt, A K et al.

Part of Heart, p. 1141-1147, 2005

DOI for Cardiovascular risk factors and clinical presentation in acute coronary syndromes

Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes

Mälarstig, Anders; Tenno, Taavo; Johnston, Nina; Lagerqvist, Bo et al.

Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 2667-2672, 2005

DOI for Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes

Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease

Oldgren, Jonas; Fellenius, C.; Boman, K.; Jansson, J-H. et al.

Part of Journal of Internal Medicine, p. 420-7, 2005

DOI for Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease

Development of myocardial microcirculation and metabolism in acute ST-elevation myocardial infarction evaluated with positron emission tomography

Frostfeldt, Gunnar; Sörensen, Jens; Lindahl, Bertil; Valind, Sven et al.

Part of Journal of Nuclear Cardiology, p. 43-54, 2005

DOI for Development of myocardial microcirculation and metabolism in acute ST-elevation myocardial infarction evaluated with positron emission tomography

Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI

Björklund, Erik; Stenestrand, Ulf; Lindbäck, Johan; Svensson, Leif et al.

Part of Journal of Electrocardiology, p. 186, 2005

DOI for Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI

Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS

Dotevall, A; Hasdai, D; Wallentin, Lars; Battler, A et al.

Part of Diabetic Medicine, p. 1542-1550, 2005

FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease

Lagerqvist, B; Diderholm, E; Lindahl, B; Husted, S et al.

Part of Heart, p. 1047-1052, 2005

DOI for FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease

An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease

James, Stefan K; Oldgren, Jonas; Lindbäck, Johan; Johnston, Nina et al.

Part of American Heart Journal, p. 619-626, 2005

DOI for An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease

Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial

Welsh, R C; Chang, W; Goldstein, P; Adgey, J et al.

Part of Heart, p. 1400-1406, 2005

DOI for Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy

Lindahl, Bertil; Lindbäck, Johan; Jernberg, Tomas; Johnston, Nina et al.

Part of Journal of the American College of Cardiology, p. 533-541, 2005

DOI for Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy

Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy

Ripa, Rasmus S.; Holmvang, Lene; Maynard, Charles; Sejersten, Maria et al.

Part of Journal of Electrocardiology, p. 180-6, 2005

DOI for Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy

Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction

Christersson, Christina; Oldgren, Jonas; Bylock, A.; Wallentin, Lars et al.

Part of Journal of Thrombosis and Haemostasis, p. 2245-53, 2005

DOI for Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction

NT-ProBNP in non-ST-elevation acute coronary syndrome.

Jernberg, Tomas; James, Stefan; Lindahl, Bertil; Stridsberg, Mats et al.

Part of J Card Fail, 2005

Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).

Stenestrand, Ulf; Lindbäck, Johan; Wallentin, Lars

Part of Circulation, p. 3225-31, 2005

Treatment of acute coronary syndromes: have we reached the ceiling?

Wallentin, Lars

Part of Nat Clin Pract Cardiovasc Med, p. 173, 2005

A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy.

Johanson, Per; Fu, Yuling; Goodman, Shaun G; Dellborg, Mikael et al.

Part of Eur Heart J, p. 1726-33, 2005

Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.

Mehta, Shamir R; Cannon, Christopher P; Fox, Keith A A; Wallentin, Lars et al.

Part of JAMA, p. 2908-17, 2005

Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis.

Chang, Wei-Ching; Midodzi, William K; Westerhout, Cynthia M; Boersma, Eric et al.

Part of J Epidemiol Community Health, p. 427-33, 2005

[Insights and views about cardiovascular safety of COX2 inhibitors]

Wallentin, Lars

Part of Lakartidningen, 2005

Hospital therapy traditions influence long-term survival in patients with acute myocardial infarction.

Stenestrand, Ulf; Lindbäck, Johan; Wallentin, Lars

Part of Am Heart J, p. 82-90, 2005

The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice.

Flynn, M Rachel; Barrett, Conor; Cosío, Francisco G; Gitt, Anselm K et al.

Part of Eur Heart J, p. 308-13, 2005

Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study population.

Jacobsen, Michael D; Wagner, Galen S; Holmvang, Lene; Kontny, Frederic et al.

Part of Eur Heart J, p. 112-8, 2005

Prevention of cardiovascular events after acute coronary syndrome.

Wallentin, Lars

Part of Semin Vasc Med, p. 293-300, 2005

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.

James, Stefan K.; Lindahl, Bertil; Armstrong, Paul; Califf, Robert et al.

Part of International Journal of Cardiology, p. 113-120, 2004

DOI for A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST–elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy

James, Stefan K.; Siegbahn, Agneta; Armstrong, P; Barnathan, E et al.

Part of American Heart Journal, p. 267-274, 2004

DOI for Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST–elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy

Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction

Björklund, Erik; Lindahl, Bertil; Johanson, Per; Jernberg, Tomas et al.

Part of European Heart Journal, p. 113-120, 2004

DOI for Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction

Biochemical indicators of cardiac and renal function in a healthy elderly population

Johnston, Nina; Jernberg, Tomas; Lindahl, Bertil; Lindbäck, Johan et al.

Part of Clinical Biochemistry, p. 210-216, 2004

DOI for Biochemical indicators of cardiac and renal function in a healthy elderly population

Natriuretic peptides in unstable coronary artery disease

Jernberg, Tomas; James, Stefan; Lindahl, Bertil; Johnston, Nina et al.

Part of European Heart Journal, p. 1486-1493, 2004

DOI for Natriuretic peptides in unstable coronary artery disease

Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial

Björklund, Erik; Lindahl, Bertil; Stenestrand, Ulf; Swahn, Eva et al.

Part of American Heart Journal, p. 566-573, 2004

DOI for Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study

Wu, Alan H B; Packer, Milton; Smith, Andrew; Bijou, Rachel et al.

Part of Clinical Chemistry, p. 867-873, 2004

DOI for Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study

NT-proBNP in unstable coronary artery disease: experiences from the FAST, GUSTO IV and FRISC II trials

Jernberg, Tomas; James, Stefan; Lindahl, Bertil; Stridsberg, Mats et al.

Part of European Journal of Heart Failure, p. 319-325, 2004

DOI for NT-proBNP in unstable coronary artery disease: experiences from the FAST, GUSTO IV and FRISC II trials

[Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice]

James, Stefan; Lindahl, Bertil; Siegbahn, Agneta; Stridsberg, Mats et al.

Part of Lakartidningen, p. 1514-9, 1521, 2004

Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3).

Curtis, Jeptha P; Alexander, John H; Huang, Yao; Wallentin, Lars et al.

Part of Am J Cardiol, p. 279-83, 2004

Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy.

Taher, Taha; Fu, Yuling; Wagner, Galen S; Goodman, Shaun G et al.

Part of J Am Coll Cardiol, p. 38-43, 2004

Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction.

Sinnaeve, Peter R; Alexander, John H; Bogaerts, Kris; Belmans, Ann et al.

Part of Am Heart J, p. 993-8, 2004

Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome.

Jernberg, Tomas; Lindahl, Bertil; James, Stefan; Larsson, Anders et al.

Part of Circulation, p. 2342-8, 2004

ST-segment analyses and residual thrombi in the infarct-related artery: a report from the ASSENT PLUS ST-monitoring substudy.

Johanson, Per; Wallentin, Lars; Nilsson, Tage; Bergstrand, Lott et al.

Part of Am Heart J, p. 853-8, 2004

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS.

Ottervanger, J P; Armstrong, P; Barnathan, E S; Boersma, E et al.

Part of Eur Heart J, p. 1494-501, 2004

Variations in pre-hospital fibrinolysis process of care: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic 3 Plus international acute myocardial infarction pre-hospital care survey.

Welsh, Robert C; Goldstein, Patrick; Adgey, Jennifer; Verheugt, Freek et al.

Part of Eur J Emerg Med, p. 134-40, 2004

Sex, age, and clinical presentation of acute coronary syndromes.

Rosengren, Annika; Wallentin, Lars; K Gitt, Anselm; Behar, Solomon et al.

Part of Eur Heart J, p. 663-70, 2004

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.

Norhammar, Anna; Malmberg, Klas; Diderholm, Erik; Lagerqvist, Bo et al.

Part of J Am Coll Cardiol, p. 585-91, 2004

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.

Patrono, Carlo; Bachmann, Fedor; Baigent, Colin; Bode, Christopher et al.

Part of Eur Heart J, p. 166-81, 2004

Öppen redovisning av vårdinsatser och resultat vid behandling av akut hjärtinfarkt på olika sjukhus i Sverige år 2003

Wallentin, Lars; ., RIKS-HIA styrgrupp

Part of Socialmedicinsk tidskrift, p. 458-469, 2004

[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]

Lopez-Sendon, Jose; Swedberg, Karl; McMurray, John; Tamargo, Juan et al.

Part of Rev Esp Cardiol, p. 1213-32, 2004

Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.

Oldgren, Jonas; Siegbahn, Agneta; Grip, Lars; Linder, Rikard et al.

Part of Thromb Haemost, p. 381-7, 2004

Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block.

Stenestrand, Ulf; Tabrizi, Fariborz; Lindbäck, Johan; Englund, Anders et al.

Part of Circulation, p. 1896-902, 2004

Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.

Lenderink, Timo; Boersma, Eric; Ruzyllo, Witold; Widimsky, Petr et al.

Part of Am Heart J, p. 865-73, 2004

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

James, Stefan; Armstrong, Paul; Barnathan, Elliott; Califf, Robert et al.

Part of Journal of the American College of Cardiology, p. 916-24, 2003

DOI for Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

N-Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV Substudy

James, Stefan; Lindahl, Bertil; Siegbahn, Agneta; Stridsberg, Mats et al.

Part of Circulation, p. 275-281, 2003

DOI for N-Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV Substudy

Myocardial Damage, Inflammation and Thrombin Inhibition in Unstable Coronary Artery Disease

Oldgren, Jonas; Wallentin, Lars; Grip, L; Linder, R et al.

Part of European Heart Journal, p. 86-93, 2003

DOI for Myocardial Damage, Inflammation and Thrombin Inhibition in Unstable Coronary Artery Disease

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial

James, Stefan; Armstrong, Paul; Califf, Robert; Simoons, Maarten L. et al.

Part of American Journal of Medicine, p. 178-184, 2003

DOI for Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial

Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits: A FRISC-II substudy

Venge, Per; Johnston, Nina; Lagerqvist, Bo; Wallentin, Lars et al.

Part of Clinical Chemistry, p. 880-886, 2003

DOI for Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits: A FRISC-II substudy

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.

Jernberg, Tomas; Lindahl, Bertil; Siegbahn, Agneta; Andren, Bertil et al.

Part of J Am Coll Cardiol, p. 1909-16, 2003

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.

Wallentin, Lars; Goldstein, P; Armstrong, P W; Granger, C B et al.

Part of Circulation, p. 135-42, 2003

Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab.

Dubois, Christophe L; Belmans, Ann; Granger, Christopher B; Armstrong, Paul W et al.

Part of J Am Coll Cardiol, p. 1178-85, 2003

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial.

Wallentin, Lars; Wilcox, Robert G; Weaver, W Douglas; Emanuelsson, Håkan et al.

Part of Lancet, p. 789-97, 2003

ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction.

Armstrong, Paul W; Wagner, Galen; Goodman, Shaun G; Van de Werf, Frans et al.

Part of Eur Heart J, p. 1515-22, 2003

Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment.

Holmvang, Lene; Clemmensen, Peter; Lindahl, Bertil; Lagerqvist, Bo et al.

Part of J Am Coll Cardiol, p. 905-15, 2003

Prognostic value of ST-segment resolution-when and what to measure.

Johanson, Per; Jernberg, Tomas; Gunnarsson, Gunnar; Lindahl, Bertil et al.

Part of Eur Heart J, p. 337-45, 2003

Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort.

Stenestrand, Ulf; Wallentin, Lars

Part of Arch Intern Med, p. 965-71, 2003

Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.

Norhammar, Anna; Malmberg, Klas; Ryden, Lars; Tornvall, Per et al.

Part of Eur Heart J, p. 838-44, 2003

Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease.

Diderholm, Erik; Andren, Bertil; Frostfeldt, Gunnar; Genberg, Margareta et al.

Part of Am J Med, p. 606-12, 2003

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.

Wallentin, Lars; Bergstrand, Lott; Dellborg, Mikael; Fellenius, Carin et al.

Part of Eur Heart J, p. 897-908, 2003

The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy

Diderholm, Erik; Andrén, Bertil; Frostfeldt, Gunnar; Genberg, Margareta et al.

Part of American Heart Journal, p. 760-767, 2002

DOI for The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.

Aviles, Ronnier J; Askari, Arman T; Lindahl, Bertil; Wallentin, Lars et al.

Part of N Engl J Med, p. 2047-52, 2002

Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy).

Venge, Per; Lagerqvist, Bo; Diderholm, Erik; Lindahl, Bertil et al.

Part of Am J Cardiol, p. 1035-41, 2002

Observer variability and optimal criteria of transient ischemia during ST monitoring with continuous 12-lead ECG.

Jernberg, Tomas; Cronblad, Jörgen; Lindahl, Bertil; Wallentin, Lars

Part of Ann Noninvasive Electrocardiol, p. 181-90, 2002

Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment.

Jernberg, Tomas; Abrahamsson, P; Lindahl, Bertil; Johanson, P et al.

Part of Eur Heart J, p. 1093-101, 2002

ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease; the FRISC II ECG substudy. The Fast Revascularisation during InStability in Coronary artery disease.

Diderholm, Erik; Andren, Bertil; Frostfeldt, Gunnar; Genberg, M et al.

Part of Eur Heart J, p. 41-9, 2002

Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization.

Husted, S E; Wallentin, L; Lagerqvist, B; Kontny, F et al.

Part of Eur Heart J, p. 1213-8, 2002

Influence on coagulation activity by subcutaneous LMW heparin as an adjuvant treatment to fibrinolysis in acute myocardial infarction.

Frostfeldt, Gunnar; Gustavsson, Gunnar; Lindahl, Bertil; Nygren, Anders et al.

Part of Thromb Res, p. 193-9, 2002

Persistence of the prothrombotic state after acute coronary syndromes: implications for treatment.

Bahit, Maria Cecilia; Granger, Christopher B; Wallentin, Lars

Part of Am Heart J, p. 205-16, 2002

Possible reasons for the prognostic value of troponin-T on admission in patients with ST-elevation myocardial infarction

Frostfeldt, Gunnar; Gustafsson, Gunnar; Lindahl, Bertil; Nygren, Anders et al.

Part of Coronary Artery Disease, p. 227-237, 2001

Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy

Lindahl, Bertil; Diderholm, Erik; Lagerqvist, Bo; Venge, Per et al.

Part of Journal of the American College of Cardiology, p. 979-986, 2001

DOI for Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy

The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: the ASSENT PLUS study.

Wallentin, Lars; Dellborg, D M; Lindahl, Bertil; Nilsson, T et al.

Part of Clin Cardiol, 2001

Comparison of continuous vectorcardiography and continuous 12-lead electrocardiography of patients with unstable coronary artery disease: do they identify the same population?

Jernberg, Tomas; Abrahamsson, P; Lindahl, Bertil; Wallentin, Lars et al.

Part of Coron Artery Dis, p. 187-95, 2001

New generation cardiac troponin I assay for the access immunoassay system.

Venge, P; Lindahl, Bertil; Wallentin, Lars

Part of Clin Chem, p. 959-61, 2001

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy.

Lindmark, E; Diderholm, E; Wallentin, L; Siegbahn, A

Part of JAMA, p. 2107-13, 2001

Combination of continuous 12-lead ECG and troponin T: a valuable prognostic tool for early risk stratification in patients with chest pain and a non-diagnostic ECG.

Jernberg, T; Lindahl, B; Wallentin, L

Part of Eur Heart J, p. 1465, 2000

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

Bertrand, M E; Simoons, M L; Fox, K A; Wallentin, Lars et al.

Part of Eur Heart J, p. 1406-32, 2000

Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis

Ellenius, Johan; Groth, Torgny; Lindahl, Bertil; Wallentin, Lars

Part of Clinical Chemistry, p. 1919-1925, 1997

Publications

Recent publications

All publications

Articles in journal

Articles, review/survey

Chapters in book

Conference papers

Manuscripts (preprints)

Other